Put it on the Board

Create PDF

Clinical research registry aims to answer crucial COVID-19 questions

May 2020—A Healthcare Worker Exposure Response and Outcomes Registry was launched April 13 to unite health care workers in the U.S. for rapid-cycle research.

The goals of the so-called HERO registry are to engage workers in a research community, understand their experiences, and track outcomes associated with caring for patients with COVID-19.

The HERO research program, led by Duke Clinical Research Institute, part of Duke University School of Medicine, leverages the National Patient-Centered Clinical Research Network, known as PCORnet, and is funded by the Patient-Centered Outcomes Research Institute, or PCORI.

Anyone who works in a setting in which people receive health care is being invited to join the registry. Enrollees will receive surveys, information about participating in studies, and learnings from the HERO research community, and they can participate as much or as little as they wish. The registry will follow a protocol developed by Duke Clinical Research Institute and data guidelines to keep worker information secure.

To learn more about the registry, visit https://heroesresearch.org.

Randox unveils whole pathogen molecular controls for SARS-CoV-2

Whole pathogen quality controls developed in the UK to support accurate coronavirus testing are available from Randox Laboratories.

Alongside Randox’s Coronavirus Biochip, which includes tests for SARS-CoV-2 and nine other respiratory viruses, the third-party quality controls are used to ensure accurate coronavirus test and system performance. They’re available under the brand name Qnostics.